Objective: To report successful limb-sparing surgery in a dog with a proximal femoral osteosarcoma (OSA) using a composite allograft-prosthetic technique.
Study Design: Case report.
Animal: Client-owned dog.
Methods: A stage IIB OSA of the proximal aspect of the femur was resected in accordance with oncologic and limb-sparing principles. The osseous defect was reconstructed with a proximal femoral allograft and cemented, long-stemmed femoral prosthesis. Soft tissue reconstruction was achieved by suturing host tendons to their respective allogeneic tendons on the allograft. Coxofemoral joint function was preserved using standard total hip arthroplasty techniques.
Results: Limb-sparing surgery of the proximal aspect of the femur using a composite allograft-prosthetic technique resulted in excellent limb function. Postoperative complications included aseptic loosening of the femoral composite graft and allograft nonunion, which required revision, traumatic implant luxation, and local tumor recurrence. Limb function was excellent after surgical stabilization of the allograft nonunion but deteriorated after implant luxation 270 days postlimb-sparing surgery. Pulmonary and skeletal metastases were diagnosed and local tumor recurrence suspected 596 and 650 days postoperatively, respectively. The dog was euthanatized 688 days after limb-sparing surgery as a result of progressive local and metastatic disease.
Conclusions And Clinical Relevance: Limb-sparing surgery for dogs with primary bone tumors of the proximal aspect of the femur is feasible with good functional results.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1532-950X.2005.00013.x | DOI Listing |
JBJS Case Connect
January 2025
Morristown Medical Center, Morristown, New Jersey.
Case: We outline the management of a 10-month-old girl with an Ewing sarcoma involving the entire radius. The patient was treated with neoadjuvant chemotherapy resulting in almost a complete response. A limb-sparing procedure was performed consisting of a radical resection of the entire radius and centralization of the carpus to the ulna.
View Article and Find Full Text PDFIndian J Orthop
January 2025
Department of Orthopedics and Traumatology, Abdurrahman Yurtaslan Training and Research Hospital, Ankara, Turkey.
Background: Soft-tissue sarcoma involving the popliteal fossa remains challenging because it is difficult to achieve wide margins with limb salvage in this location. Adjuvant therapy is frequently necessary, and limb function can be adversely affected. We reviewed our experience with these tumors.
View Article and Find Full Text PDFCureus
November 2024
Plastic and Reconstructive Surgery, National Cancer Center Hospital East, Chiba, JPN.
Purpose Adjuvant chemotherapy (AC) following limb-sparing surgery with endoprosthesis is the gold standard treatment for osteosarcoma (OS). However, AC can impair wound healing, leading to endoprosthesis exposure, making the decision to continue or pause AC important. We propose standard guidelines for managing this situation.
View Article and Find Full Text PDFESMO Open
December 2024
Department of Surgical Oncology, Fondazione IRCCS, Istituto Nazionale die Tumori, Via Giacomo Venezian, Milano, Italy. Electronic address:
Tierarztl Prax Ausg K Kleintiere Heimtiere
December 2024
Department for Companion Animals and Horses, University Clinic for Small Animals, Small Animal Surgery, University of Veterinary Medicine Vienna, Austria.
Objective: This literature review aims to provide an overview of the existing literature on intraosseous transcutaneous amputation prosthesis (ITAP) and stump socket prosthesis in amputated animals. The goal is to compare the advantages and disadvantages of ITAP with exoprosthesis use, given the importance of limb-sparing procedures in contemporary veterinary medicine.
Materials And Methods: A systematic research adhering to the PRISMA protocol was conducted using a time span from 2000 to 2023, focusing on papers detailing the clinical application of ITAP or exoprosthesis in small animals.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!